Home | By sponsor

CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY

Trials shown by sponsor

Public title Date of Registration State
CENTAURO-4 Study 30/04/2017 Registered
HEBERBIOVAC HB vaccine to reference material. 30/04/2017 Registered
COURAGE Study 27/05/2016 Registered
ESAR-814 Study 26/01/2017 Registered
CIGB-500 in acute myocardial infarction (AMIGOS study) 23/04/2014 Registered
DENIS Study 22/10/2018 Registered
Interferon Combination in basal cell carcinoma (InCarbacel-IV study) 22/08/2013 Registered
Safety and pharmacokinetics of CIGB-552 22/05/2015 Registered
CIGB-247 vaccine in patients with solid malignant tumors, phase I, randomized. (CENTAURO-2 study) 2013-06-06 Registered
Diphenhydramine previous to CIGB-300 in cervical carcinoma (CERVISEG-II Study) 2013-05-16 Registered
Pharmacokinetics of the Intralesional administration of rhEGF (doses: 75 µg and 225 µg) in advance Diabetic Foot Ulcers 2013-02-08 Registered
Squamous cell carcinoma interferons (CECIN study) 2013-02-01 Registered
Interferon Combination in basal cell carcinoma (InCarbacel-V study) 2013-02-01 Registered
Safety with interferon in skin carcinomas (SCIENCE study) 2013-01-30 Registered
Safety and Pharmacology of CIGB-300 in cervical cancer (CERVIFARM-300 Study) 2013-01-18 Registered
Biodistribution of CIGB-300 in cervical cancer (CERVIFARM-300-II Study) 2013-01-18 Registered
Intravenous CIGB-128-A in patients with brain tumors (BRATINC Study) 2013-01-17 Registered
NASVAC Phase II Trial in patients with Chronic Hepatitis B Virus infection 2012-10-12 Registered
Quimi-Hib® and Quimi-Hib(AlPO4) vaccines in an accelerated 6-10-14 weeks primary vaccination series 2012-09-12 Registered
HeberPAG® in Mycosis Fungoides (MYFIC Study) 2012-06-08 Registered